←Back to Expert Scholars
Translational Medicine / 转化医学Chemoprevention, Breast Cancer
Victor Vogel
MD, MHS
🏢Geisinger Health System🌐USA
National Consultant in Breast Oncology
70
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Victor Vogel co-led the STAR trial comparing tamoxifen and raloxifene for breast cancer prevention in postmenopausal women at high risk. He has contributed to NSABP risk assessment and prevention efforts throughout his career. He consults in breast oncology at Geisinger.
Share:
🧪Research Fields 研究领域
STAR trial
raloxifene
tamoxifen
breast cancer risk assessment
NSABP
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Victor Vogel 的研究动态
Follow Victor Vogel's research updates
留下邮箱，当我们发布与 Victor Vogel（Geisinger Health System）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment